SOBECO

About

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is SOBECO's primary focus?

SOBECO is a partnership focused on developing bio-medical products, specifically a drug designed to quickly reduce alcohol intoxication and its negative effects.

When was SOBECO established?

SOBECO was established in November 2011.

What is SOBECO's current operational status?

SOBECO is currently inactive, as of December 2016.

What is the main objective of SOBECO's drug development?

The main objective of SOBECO's drug development is to reduce alcohol-related car accidents and make alcohol consumption safer by quickly eliminating the negative effects of alcohol after moderate drinking.

Where is SOBECO's headquarters located?

SOBECO's headquarters is located in Tel Aviv-Yafo, Israel, at 3 Hadasa st.

What is SOBECO's primary sector classification?

SOBECO's primary sector classification is Health Tech & Life Sciences, with further classifications in Pharma & Medical Biotechnology and Drugs Discovery & Development.

What is SOBECO's employee count?

SOBECO has an employee count of 6, falling into the 1-10 employee bucket.

What is SOBECO's current funding stage?

SOBECO is currently in the Pre-Funding stage.

Who is a founder of SOBECO?

Amit Mizrahi is a founder of SOBECO.

Sectors & technology

Highlights

Tags